New pill shows promise for severe eczema sufferers

NCT ID NCT07217015

Ongoing Disease control Sponsor: Kymera Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tests an oral medication called KT-621 for people aged 12 to 75 with moderate-to-severe atopic dermatitis (eczema). The goal is to see if it reduces skin redness, itching, and affected body area compared to a placebo. The trial lasts 16 weeks with a follow-up open-label period of 52 weeks, and involves about 200 participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Show contact details

Locations

Kymera Investigative Site

Ann Arbor, Michigan, 48103, United States
Kymera Investigative Site

Detroit, Michigan, 48202, United States
Kymera Investigative Site

The Bronx, New York, 10455, United States
Kymera Investigative Site

Fargo, North Dakota, 58103, United States
Kymera Investigative Site

Portland, Oregon, 97201, United States
Kymera Investigative Site

Portland, Oregon, 97239, United States
Kymera Investigative Site

Philadelphia, Pennsylvania, 19103, United States
Kymera Investigative Site

San Antonio, Texas, 78213, United States
Kymera Investigative Site

San Antonio, Texas, 78218, United States
Kymera Investigative Site

Darlinghurst, New South Wales, Australia
Kymera Investigative Site

Kogarah, New South Wales, Australia
Kymera Investigative Site

Brisbane, Queensland, Australia
Kymera Investigative Site

Woolloongabba, Queensland, Australia
Kymera Investigative Site

Melbourne, Victoria, Australia
Kymera Investigative Site

Calgary, Alberta, Canada
Kymera Investigative Site

Edmonton, Alberta, Canada
Kymera Investigative Site

Kelowna, British Columbia, Canada
Kymera Investigative Site

Surrey, British Columbia, Canada
Kymera Investigative Site

Markham, Ontario, Canada
Kymera Investigative Site

Ottawa, Ontario, Canada
Kymera Investigative Site

Richmond Hill, Ontario, Canada
Kymera Investigative Site

Toronto, Ontario, Canada
Kymera Investigative Site

Windsor, Ontario, Canada
Kymera Investigative Site

Québec, Quebec, Canada
Kymera Investigative Site

Pardubice, Czechia
Kymera Investigative Site

Prague, Czechia
Kymera Investigative Site

Augsburg, Bavaria, Germany
Kymera Investigative Site

München, Bavaria, Germany
Kymera Investigative Site

Bad Bentheim, Germany
Kymera Investigative Site

Berlin, Germany
Kymera Investigative Site

Dresden, Germany
Kymera Investigative Site

Frankfurt, Germany
Kymera Investigative Site

Friedrichshafen, Germany
Kymera Investigative Site

Mainz, Germany
Kymera Investigative Site

Münster, Germany
Kymera Investigative Site

Ichikawa, Chiba, Japan
Kymera Investigative Site

Kagoshima, Japan
Kymera Investigative Site

Kanagawa, Japan
Kymera Investigative Site

Nagoya, Japan
Kymera Investigative Site

Osaka, Japan
Kymera Investigative Site

Sakai, Japan
Kymera Investigative Site

Sapporo, Japan
Kymera Investigative Site

Chorzów, Poland
Kymera Investigative Site

Gdansk, Poland
Kymera Investigative Site

Gdynia, Poland
Kymera Investigative Site

Krakow, Poland
Kymera Investigative Site

Lublin, Poland
Kymera Investigative Site

Rzeszów, Poland
Kymera Investigative Site

Szczecin, Poland
Kymera Investigative Site

Warsaw, Poland
Kymera Investigative Site

Wroclaw, Poland
Kymera Investigative Site

Ansan-si, South Korea
Kymera Investigative Site

Cheonan, South Korea
Kymera Investigative Site

Gyeonggi-do, South Korea
Kymera Investigative Site

Incheon, South Korea
Kymera Investigative Site

Seoul, South Korea
Kymera Investigative Site

Birmingham, Alabama, 35244, United States
Kymera Investigative Site

North Little Rock, Arkansas, 72117, United States
Kymera Investigative Site

Freemont, California, 94538, United States
Kymera Investigative Site

Los Angeles, California, 90025, United States
Kymera Investigative Site

Los Angeles, California, 90045, United States
Kymera Investigative Site

Santa Monica, California, 91350, United States
Kymera Investigative Site

Delray Beach, Florida, 33484, United States
Kymera Investigative Site

Jacksonville, Florida, 32256, United States
Kymera Investigative Site

Miami, Florida, 33137, United States
Kymera Investigative Site

Miramar, Florida, 33027, United States
Kymera Investigative Site

Normal, Illinois, 61761, United States
Kymera Investigative Site

Indianapolis, Indiana, 46202, United States